vs
Side-by-side financial comparison of Arcellx, Inc. (ACLX) and Axil Brands, Inc. (AXIL). Click either name above to swap in a different company.
Axil Brands, Inc. is the larger business by last-quarter revenue ($8.1M vs $8.1M, roughly 1.0× Arcellx, Inc.). Axil Brands, Inc. runs the higher net margin — 8.7% vs -766.0%, a 774.7% gap on every dollar of revenue. On growth, Axil Brands, Inc. posted the faster year-over-year revenue change (5.2% vs -79.3%). Axil Brands, Inc. produced more free cash flow last quarter ($906.4K vs $-63.9M). Over the past eight quarters, Axil Brands, Inc.'s revenue compounded faster (12.1% CAGR vs -24.6%).
Arcellx, Inc. is a clinical-stage biotechnology company that develops innovative chimeric antigen receptor T (CAR-T) cell therapies for treating hard-to-treat cancers including hematologic malignancies and solid tumors. Its core pipeline targets unmet oncology medical needs, serving global patient populations and partnering with life sciences stakeholders.
Axil Brands, Inc. is a U.S.-headquartered company that designs, manufactures and markets premium hearing protection products, audio enhancement devices and personal audio accessories. Its offerings include custom-fit earplugs, Bluetooth-enabled hearing buds for work, sports and leisure use, serving both consumer and professional segments across global markets.
ACLX vs AXIL — Head-to-Head
Income Statement — Q1 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $8.1M | $8.1M |
| Net Profit | $-62.3M | $704.9K |
| Gross Margin | — | 68.1% |
| Operating Margin | -847.6% | 11.1% |
| Net Margin | -766.0% | 8.7% |
| Revenue YoY | -79.3% | 5.2% |
| Net Profit YoY | -765.1% | 11.2% |
| EPS (diluted) | $-1.13 | $0.09 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $8.1M | ||
| Q3 25 | — | $6.9M | ||
| Q2 25 | — | $5.8M | ||
| Q1 25 | $8.1M | $6.9M | ||
| Q4 24 | $15.3M | $7.7M | ||
| Q3 24 | $26.0M | $5.9M | ||
| Q2 24 | $27.4M | $6.5M | ||
| Q1 24 | $39.3M | $6.5M |
| Q4 25 | — | $704.9K | ||
| Q3 25 | — | $334.3K | ||
| Q2 25 | — | $-245.6K | ||
| Q1 25 | $-62.3M | $576.7K | ||
| Q4 24 | $-47.1M | $633.7K | ||
| Q3 24 | $-25.9M | $-109.8K | ||
| Q2 24 | $-27.2M | $49.5K | ||
| Q1 24 | $-7.2M | $781.1K |
| Q4 25 | — | 68.1% | ||
| Q3 25 | — | 67.6% | ||
| Q2 25 | — | 70.0% | ||
| Q1 25 | — | 71.7% | ||
| Q4 24 | — | 71.1% | ||
| Q3 24 | — | 71.0% | ||
| Q2 24 | — | 71.5% | ||
| Q1 24 | — | 71.5% |
| Q4 25 | — | 11.1% | ||
| Q3 25 | — | 6.0% | ||
| Q2 25 | — | 0.8% | ||
| Q1 25 | -847.6% | 8.4% | ||
| Q4 24 | -348.2% | 8.7% | ||
| Q3 24 | -129.1% | -2.4% | ||
| Q2 24 | -127.8% | 2.6% | ||
| Q1 24 | -40.3% | -1.6% |
| Q4 25 | — | 8.7% | ||
| Q3 25 | — | 4.9% | ||
| Q2 25 | — | -4.3% | ||
| Q1 25 | -766.0% | 8.3% | ||
| Q4 24 | -308.4% | 8.2% | ||
| Q3 24 | -99.4% | -1.9% | ||
| Q2 24 | -99.3% | 0.8% | ||
| Q1 24 | -18.3% | 12.1% |
| Q4 25 | — | $0.09 | ||
| Q3 25 | — | $0.04 | ||
| Q2 25 | — | $-0.03 | ||
| Q1 25 | $-1.13 | $0.07 | ||
| Q4 24 | $-0.87 | $0.08 | ||
| Q3 24 | $-0.48 | $-0.02 | ||
| Q2 24 | $-0.51 | $0.11 | ||
| Q1 24 | $-0.14 | $0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $543.3M | $5.0M |
| Total DebtLower is stronger | — | $138.3K |
| Stockholders' EquityBook value | $416.9M | $11.1M |
| Total Assets | $648.1M | $16.2M |
| Debt / EquityLower = less leverage | — | 0.01× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $5.0M | ||
| Q3 25 | — | $4.1M | ||
| Q2 25 | — | $4.8M | ||
| Q1 25 | $543.3M | $4.7M | ||
| Q4 24 | $587.4M | $5.2M | ||
| Q3 24 | $574.3M | $4.1M | ||
| Q2 24 | $516.7M | $3.3M | ||
| Q1 24 | $573.9M | $4.9M |
| Q4 25 | — | $138.3K | ||
| Q3 25 | — | $139.2K | ||
| Q2 25 | — | $140.2K | ||
| Q1 25 | — | $141.0K | ||
| Q4 24 | — | $143.3K | ||
| Q3 24 | — | $144.3K | ||
| Q2 24 | — | $146.6K | ||
| Q1 24 | — | — |
| Q4 25 | — | $11.1M | ||
| Q3 25 | — | $10.2M | ||
| Q2 25 | — | $9.7M | ||
| Q1 25 | $416.9M | $9.7M | ||
| Q4 24 | $454.8M | $8.8M | ||
| Q3 24 | $483.0M | $7.9M | ||
| Q2 24 | $487.2M | $7.7M | ||
| Q1 24 | $496.6M | $8.8M |
| Q4 25 | — | $16.2M | ||
| Q3 25 | — | $15.4M | ||
| Q2 25 | — | $12.9M | ||
| Q1 25 | $648.1M | $13.0M | ||
| Q4 24 | $711.3M | $13.7M | ||
| Q3 24 | $764.9M | $11.4M | ||
| Q2 24 | $734.3M | $11.0M | ||
| Q1 24 | $779.7M | $12.7M |
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.01× | ||
| Q1 25 | — | 0.01× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.02× | ||
| Q2 24 | — | 0.02× | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-63.1M | $934.8K |
| Free Cash FlowOCF − Capex | $-63.9M | $906.4K |
| FCF MarginFCF / Revenue | -786.4% | 11.1% |
| Capex IntensityCapex / Revenue | 9.6% | 0.3% |
| Cash ConversionOCF / Net Profit | — | 1.33× |
| TTM Free Cash FlowTrailing 4 quarters | $-122.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $934.8K | ||
| Q3 25 | — | $-739.2K | ||
| Q2 25 | — | $194.4K | ||
| Q1 25 | $-63.1M | $-169.9K | ||
| Q4 24 | $-46.0M | $1.0M | ||
| Q3 24 | $30.7M | $897.3K | ||
| Q2 24 | $-36.2M | $-336.6K | ||
| Q1 24 | $-31.9M | $-912.8K |
| Q4 25 | — | $906.4K | ||
| Q3 25 | — | $-747.6K | ||
| Q2 25 | — | — | ||
| Q1 25 | $-63.9M | $-258.2K | ||
| Q4 24 | $-47.5M | $941.1K | ||
| Q3 24 | $28.4M | — | ||
| Q2 24 | $-39.5M | $-394.9K | ||
| Q1 24 | $-38.3M | $-922.1K |
| Q4 25 | — | 11.1% | ||
| Q3 25 | — | -10.9% | ||
| Q2 25 | — | — | ||
| Q1 25 | -786.4% | -3.7% | ||
| Q4 24 | -311.3% | 12.2% | ||
| Q3 24 | 109.2% | — | ||
| Q2 24 | -144.1% | -6.1% | ||
| Q1 24 | -97.7% | -14.3% |
| Q4 25 | — | 0.3% | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | — | ||
| Q1 25 | 9.6% | 1.3% | ||
| Q4 24 | 9.8% | 0.9% | ||
| Q3 24 | 8.8% | — | ||
| Q2 24 | 11.7% | 0.9% | ||
| Q1 24 | 16.4% | 0.1% |
| Q4 25 | — | 1.33× | ||
| Q3 25 | — | -2.21× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -0.29× | ||
| Q4 24 | — | 1.59× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -6.80× | ||
| Q1 24 | — | -1.17× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACLX
Segment breakdown not available.
AXIL
| Hearing Enhancement And Protection | $7.8M | 95% |
| Other | $378.9K | 5% |
